Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
Hôpital André Mignot · Assistance Publique – Hôpitaux de Paris · +21 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
989
total citations
- FWCI
- 41.45
- Percentile
- 100%
- References
- 33
Citations per year
Authors
22- SCSylvie CastaignéCorresponding
Hôpital André Mignot
- CPCécile Pautas
Assistance Publique – Hôpitaux de Paris, Université Paris-Est Créteil
- CTChristine Terré
Hôpital André Mignot
- EREmmanuel Raffoux
Université Paris Cité, Hôpital Saint-Louis, Délégation Paris 7, Assistance Publique – Hôpitaux de Paris
- DBDominique Bordessoule
Centre Hospitalier Universitaire de Limoges
Topics & keywords
Topics
Keywords
- Gemtuzumab ozogamicin
- Medicine
- Internal medicine
- Calicheamicin
- Clinical endpoint
- Chemotherapy
- Hematology
- Surgery
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.